• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆前蛋白转化酶枯草溶菌素9(PCSK9)水平在男性中与胆固醇相关,但在女性中则不然。

Plasma PCSK9 levels correlate with cholesterol in men but not in women.

作者信息

Mayne Janice, Raymond Angela, Chaplin Anna, Cousins Marion, Kaefer Nadine, Gyamera-Acheampong Charles, Seidah Nabil G, Mbikay Majambu, Chrétien Michel, Ooi Teik Chye

机构信息

Hormones, Growth and Development Program, Ottawa Health Research Institute, The Ottawa Hospital, University of Ottawa, Ottawa, Ont., Canada.

出版信息

Biochem Biophys Res Commun. 2007 Sep 21;361(2):451-6. doi: 10.1016/j.bbrc.2007.07.029. Epub 2007 Jul 18.

DOI:10.1016/j.bbrc.2007.07.029
PMID:17645871
Abstract

Proprotein convertase subtilisin kexin-like 9 (PCSK9) is a secreted glycoprotein that negatively regulates low density lipoprotein receptor (LDLR) levels. Several single nucleotide polymorphisms (SNPs) in PCSK9 have been linked to autosomal dominant hypercholesterolemia (ADH). Conversely, hypocholesterolemia associates with both 'loss of function' nonsense and missense SNPs in PCSK9. We examined the association of plasma PCSK9 with lipoprotein parameters in 182 normolipidemics. For men (n=98) plasma PCSK9 averaged 6.08+/-1.96 microg/ml and Spearman analysis revealed significant correlation between it and total cholesterol (TC), LDLC, and TC/high density lipoprotein (HDLC) (r=0.276, 0.282, and 0.228, respectively). For women (n=84) plasma PCSK9 averaged 6.46+/-1.99 microg/ml having no correlation with TC, LDLC or TC/HDLC. The ratio of plasma PCSK9/LDLC increased in men carrying 'loss of function' PCSK9 variations. Our results suggest a gender difference in PCSK9 regulation and function with PCSK9 correlated to TC and LDLC in men but not women.

摘要

前蛋白转化酶枯草溶菌素9型(PCSK9)是一种分泌型糖蛋白,可负向调节低密度脂蛋白受体(LDLR)水平。PCSK9中的几个单核苷酸多态性(SNP)与常染色体显性高胆固醇血症(ADH)相关。相反,低胆固醇血症与PCSK9中“功能丧失”的无义及错义SNP相关。我们在182名血脂正常者中研究了血浆PCSK9与脂蛋白参数之间的关联。对于男性(n = 98),血浆PCSK9平均为6.08±1.96微克/毫升,Spearman分析显示其与总胆固醇(TC)、低密度脂蛋白胆固醇(LDLC)以及TC/高密度脂蛋白胆固醇(HDLC)之间存在显著相关性(r分别为0.276、0.282和0.228)。对于女性(n = 84),血浆PCSK9平均为6.46±1.99微克/毫升,与TC、LDLC或TC/HDLC无相关性。携带“功能丧失”型PCSK9变异的男性血浆PCSK9/LDLC比值升高。我们的结果表明,PCSK9在调节和功能方面存在性别差异,PCSK9在男性中与TC和LDLC相关,而在女性中则不然。

相似文献

1
Plasma PCSK9 levels correlate with cholesterol in men but not in women.血浆前蛋白转化酶枯草溶菌素9(PCSK9)水平在男性中与胆固醇相关,但在女性中则不然。
Biochem Biophys Res Commun. 2007 Sep 21;361(2):451-6. doi: 10.1016/j.bbrc.2007.07.029. Epub 2007 Jul 18.
2
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways.家族性高胆固醇血症患者的前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9 血清水平表明,前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9 通过 LDL 受体非依赖途径从血浆中清除。
Transl Res. 2012 Aug;160(2):125-30. doi: 10.1016/j.trsl.2012.01.010. Epub 2012 Jan 31.
3
Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study.肾病综合征和腹膜透析患者的血浆 PCSK9:一项横断面研究。
Am J Kidney Dis. 2014 Apr;63(4):584-9. doi: 10.1053/j.ajkd.2013.10.042. Epub 2013 Dec 4.
4
ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.ABO血型与血浆脂质及前蛋白转化酶枯草溶菌素/kexin 9型的关系
Nutr Metab Cardiovasc Dis. 2015 Apr;25(4):411-7. doi: 10.1016/j.numecd.2014.10.015. Epub 2014 Nov 5.
5
Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects.前蛋白转化酶枯草溶菌素9(PCSK9)基因多态性对巴西人群血脂及阿托伐他汀治疗反应的影响。
J Clin Lipidol. 2014 May-Jun;8(3):256-64. doi: 10.1016/j.jacl.2014.02.008. Epub 2014 Mar 5.
6
Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9.血浆脂蛋白相关磷脂酶 A2 与前蛋白转化酶枯草溶菌素 9 呈负相关。
Arch Med Res. 2012 Jan;43(1):11-4. doi: 10.1016/j.arcmed.2012.01.001. Epub 2012 Jan 31.
7
PCSK9 gene mutations and low-density lipoprotein cholesterol.前蛋白转化酶枯草溶菌素9基因变异与低密度脂蛋白胆固醇
Clin Chim Acta. 2014 Apr 20;431:148-53. doi: 10.1016/j.cca.2014.01.043. Epub 2014 Feb 8.
8
Of PCSK9, cholesterol homeostasis and parasitic infections: possible survival benefits of loss-of-function PCSK9 genetic polymorphisms.
Med Hypotheses. 2007;69(5):1010-7. doi: 10.1016/j.mehy.2007.03.018. Epub 2007 May 14.
9
Plasma PCSK9 levels are significantly modified by statins and fibrates in humans.在人类中,他汀类药物和贝特类药物可显著改变血浆前蛋白转化酶枯草溶菌素9(PCSK9)水平。
Lipids Health Dis. 2008 Jun 11;7:22. doi: 10.1186/1476-511X-7-22.
10
Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol.血清前蛋白转化酶枯草溶菌素9型与血清低密度脂蛋白胆固醇直接相关。
Clin Chem. 2007 Oct;53(10):1814-9. doi: 10.1373/clinchem.2007.091280. Epub 2007 Aug 16.

引用本文的文献

1
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside.靶向前蛋白转化酶枯草溶菌素 9(PCSK9):从实验室到临床。
Signal Transduct Target Ther. 2024 Jan 8;9(1):13. doi: 10.1038/s41392-023-01690-3.
2
Identification of amino acid residues in the MT-loop of MT1-MMP critical for its ability to cleave low-density lipoprotein receptor.鉴定MT1-MMP的MT环中对其切割低密度脂蛋白受体能力至关重要的氨基酸残基。
Front Cardiovasc Med. 2022 Aug 25;9:917238. doi: 10.3389/fcvm.2022.917238. eCollection 2022.
3
The Multifaceted Biology of PCSK9.
载脂蛋白 C-III(APOC3)基因的多态性与甘油三酯水平升高和心血管疾病(CVD)风险增加有关。
Endocr Rev. 2022 May 12;43(3):558-582. doi: 10.1210/endrev/bnab035.
4
Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes.2 型糖尿病患者血清 PCSK9 与 PTX3 及载脂蛋白 B、A1 和 C3 浓度相关。
Cardiovasc Ther. 2021 Dec 21;2021:7956161. doi: 10.1155/2021/7956161. eCollection 2021.
5
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels Predict Future Cardiovascular Event Risks in Hemodialyzed Black African Patients.循环中的前蛋白转化酶枯草杆菌蛋白酶/克新蛋白酶9水平可预测接受血液透析的非洲裔黑人患者未来发生心血管事件的风险。
Rambam Maimonides Med J. 2021 Jul 20;12(3):e0020. doi: 10.5041/RMMJ.10443.
6
Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis.膜型 1 基质金属蛋白酶促进 LDL 受体脱落,加速动脉粥样硬化的发展。
Nat Commun. 2021 Mar 25;12(1):1889. doi: 10.1038/s41467-021-22167-3.
7
Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data.甲氨蝶呤可降低银屑病患者中前致动脉粥样硬化血脂谱风险的新型指标——前蛋白转化酶枯草溶菌素9(PCSK9)的水平:初步数据
J Clin Med. 2020 Mar 26;9(4):910. doi: 10.3390/jcm9040910.
8
A New Liver Expression Quantitative Trait Locus Map From 1,183 Individuals Provides Evidence for Novel Expression Quantitative Trait Loci of Drug Response, Metabolic, and Sex-Biased Phenotypes.从 1183 个人体中绘制出新的肝脏表达数量性状基因座图谱,为药物反应、代谢和性别偏倚表型的新表达数量性状基因座提供了证据。
Clin Pharmacol Ther. 2020 Jun;107(6):1383-1393. doi: 10.1002/cpt.1751. Epub 2020 Jan 30.
9
Genotyping and Frequency of Variations Among Hypercholesterolemic and Diabetic Subjects.高胆固醇血症和糖尿病患者的基因分型及变异频率
Indian J Clin Biochem. 2019 Oct;34(4):444-450. doi: 10.1007/s12291-018-0763-9. Epub 2018 Jul 30.
10
Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway.循环中前蛋白转化酶枯草溶菌素9与心肌梗死风险:挪威的HUNT研究
JACC Basic Transl Sci. 2016 Nov 30;1(7):568-575. doi: 10.1016/j.jacbts.2016.06.007. eCollection 2016 Dec.